PMC4599051_01
Computed tomography scan obtained on December 24, 2014 (7 days before treatment).. Notes: Scan demonstrates a mass in the upper lobe of the left lung, multiple enlarged lymph nodes in the mediastinum, and pleural effusion; arrow indicates abundant pericardial effusion around the pericardium.
ott-8-2767Fig1.jpg
PMC4599051_01_ott-8-2767Fig1.jpg
f1-ott-8-2767
A computed tomography (CT) scan revealed a mass in the upper lobe of the left lung, multiple enlarged lymph nodes in the mediastinum, pleural effusion, and abundant PCE (Figure 1).
Pericardial effusion-volume changes seen on a computed tomography image obtained on February 9, 2015 (2 months after bevacizumab treatment).
ott-8-2767Fig2.jpg
PMC4599051_01_ott-8-2767Fig2.jpg
f2-ott-8-2767
CT scans (Figures 2 and 3) and an ultrasonogram (Figure 4) did not show effusion in any of the three follow-up examinations.
Pericardial effusion-volume changes seen on a computed tomography scan obtained on March 31, 2015 (4 months after bevacizumab treatment).
ott-8-2767Fig3.jpg
PMC4599051_01_ott-8-2767Fig3.jpg
f3-ott-8-2767
CT scans (Figures 2 and 3) and an ultrasonogram (Figure 4) did not show effusion in any of the three follow-up examinations.
Pericardial effusion-volume changes seen on an ultrasonogram obtained on May 5, 2015 (5 months after bevacizumab treatment).
ott-8-2767Fig4.jpg
PMC4599051_01_ott-8-2767Fig4.jpg
f4-ott-8-2767
CT scans (Figures 2 and 3) and an ultrasonogram (Figure 4) did not show effusion in any of the three follow-up examinations.